Literature DB >> 19954825

Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.

D Tsolakidis1, F Amant, T Van Gorp, K Leunen, P Neven, I Vergote.   

Abstract

OBJECTIVES: The aim of this study was to describe the role of diaphragmatic surgery in achieving optimal debulking in patients with advanced ovarian cancer and the assessment of the relative post-operative complications.
METHODS: Retrospective review was performed of medical records of 89 patients with epithelial ovarian cancer who underwent diaphragmatic surgery during their primary debulking surgery between September 1993 and December 2007. Four different approaches were performed: coagulation (group 1), stripping (group 2), combination stripping with coagulation (group 3) and diaphragm full thickness resection (group 4). Cytoreductive outcome, morbidity, overall survival (OS) and disease-free survival (DFS) were analysed.
RESULTS: Eight (8.9%) patients had FIGO stage IIIB, 64 (72%) stage IIIC and 17 (19.1%) stage IV disease. In 20 patients (22%) the diaphragmatic disease was coagulated, in 31 patients (35%) was only stripped, in 31 patients (35%) a combination of these techniques was applied and in 7 (8%) the disease was resected with the adjacent infiltrated part of the diaphragm muscle and the pleura above it. Debulking to no residual tumor was achieved in 90%, 86%, 86% and 100% for groups 1, 2, 3 and 4 respectively. Median DFS was 15, 15, 17 and overall survival OS for groups 1, 2, and 3 was 40, 42, and 50 months respectively and was not yet reached for group 4. Minor and major complications were comparable among the groups. Pleural effusion was the most frequent associated complication and chest tube placement (17%) or thoracocentesis (12%) was necessary for the relief of respiratory distress. The perioperative mortality rate was 0%. The majority of cases were treated in the last five years of our 15-year experience.
CONCLUSIONS: Diaphragmatic surgery increases the rates of optimal primary debulking surgery and improves survival with an acceptable and manageable morbidity rate. In patients with thick (>0.3 cm) or large (>4 cm) lesions stripping the diaphragm or full thickness resection of the diaphragmatic muscle is preferred.

Entities:  

Mesh:

Year:  2009        PMID: 19954825     DOI: 10.1016/j.ygyno.2009.07.014

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.

Authors:  Stephanie Cham; Ling Chen; Caryn M St Clair; June Y Hou; Ana I Tergas; Alexander Melamed; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Am J Obstet Gynecol       Date:  2019-02-13       Impact factor: 8.661

2.  Application of J-Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer.

Authors:  Vasilios Theodoulidis; Anastasia Prodromidou; Emmanouil Stamatakis; Nicholas Alexakis; Alexandros Rodolakis; Dimitrios Haidopoulos
Journal:  Mol Clin Oncol       Date:  2022-05-18

Review 3.  Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Authors:  Shaun Hiu; Andrew Bryant; Ketankumar Gajjar; Patience T Kunonga; Raj Naik
Journal:  Cochrane Database Syst Rev       Date:  2022-08-30

4.  Complications and Outcomes of Diaphragm Surgeries in Epithelial Ovarian Malignancies.

Authors:  Amrita Datta; Ajit Sebastian; Rachel George Chandy; Vinotha Thomas; Dhanya Susan Thomas; Reka Karuppusami; Anitha Thomas; Abraham Peedicayil
Journal:  Indian J Surg Oncol       Date:  2021-09-08

Review 5.  Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Authors:  Christine Ang; Karen K L Chan; Andrew Bryant; Raj Naik; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

6.  Diaphragmatic peritonectomy versus full thickness diaphragmatic resection and pleurectomy during cytoreduction in patients with ovarian cancer.

Authors:  P N J Pathiraja; R Garruto-Campanile; R Tozzi
Journal:  Int J Surg Oncol       Date:  2013-12-18

7.  Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer.

Authors:  C J LaFargue; B T Sawyer; R E Bristow
Journal:  Gynecol Oncol Rep       Date:  2016-05-24

8.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

9.  An Italian National Survey on Ovarian Cancer Treatment at first diagnosis. There's None so Deaf as those who will not Hear.

Authors:  Vincenzo Dario Mandato; Federica Torricelli; Stefano Uccella; Debora Pirillo; Gino Ciarlini; Gabriele Ruffo; Gianluca Annunziata; Gloria Manzotti; Sandro Pignata; Lorenzo Aguzzoli
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

10.  Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer.

Authors:  Roberto Caronna; Paolo Sammartino; Maria Luisa Framarino; Bianca Maria Sollazzo; Roberto Luca Meniconi; Piero Chirletti
Journal:  World J Surg Oncol       Date:  2013-09-23       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.